ClinicalTrials.Veeva

Menu

Treatment of CFS and Fibromyalgia With HRG 80 Red Ginseng

P

Practitioners Alliance Network

Status and phase

Unknown
Early Phase 1

Conditions

Fibromyalgia
CFS

Treatments

Dietary Supplement: HRG 80 Red Ginseng

Study type

Interventional

Funder types

Other

Identifiers

NCT04599348
PAN-HRG80-2020

Details and patient eligibility

About

Will a unique form of ginseng be clinically helpful in those with chronic fatigue syndrome and fibromyalgia?

Full description

Ginseng has been shown in earlier studies to help fatigue in a number of conditions. But because of overharvesting, most ginseng is no longer have optimal levels of the active ginsenosides. A new technique has been developed to restore the level of active ginseng components those found in the wild ginseng used in earlier studies. This is available in a form called HRG 80 Red Ginseng.

The study is an open pilot study to explore whether this treatment would be helpful for improving clinical function and symptomatology in chronic fatigue syndrome and fibromyalgia. Current clinical experience is suggesting that it may be.

Enrollment

70 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. be diagnosed with CFS and/or fibromyalgia
  2. live in the United States 3 - be over 18 years of age

Exclusion criteria

  • Pregnancy

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

70 participants in 1 patient group

Active Ginseng treatment
Experimental group
Description:
People with CFS or Fibromyalgia will receive HRG 80 Red GInseng
Treatment:
Dietary Supplement: HRG 80 Red Ginseng

Trial contacts and locations

1

Loading...

Central trial contact

Jacob Teitelbaum, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems